What Is IV Therapy

IV therapy is the delivery of fluids, vitamins, minerals, amino acids, or other compounds directly into the bloodstream through a catheter placed in a vein. By bypassing the gastrointestinal tract, it allows nutrients to reach cells at concentrations that oral intake often cannot achieve. It is used in both clinical medicine and elective wellness settings, with formulations ranging from simple saline hydration to complex multi-nutrient protocols.

Nutrient status is a foundational variable in healthy aging. Deficiencies in magnesium, B vitamins, vitamin C, and zinc are associated with impaired energy production, weakened immune function, increased oxidative stress, and accelerated cellular aging. While oral supplementation addresses many gaps, absorption through the gut is inherently limited by factors like intestinal permeability, transporter saturation, enzyme activity, and competition between nutrients for uptake. For some nutrients, the gap between what oral dosing can deliver and what tissues actually need can be significant, particularly when gut function itself is compromised.

IV therapy enters the longevity conversation because it offers a way to achieve supraphysiologic plasma concentrations of specific nutrients, at least transiently. High-dose intravenous vitamin C, for instance, reaches blood levels roughly 70 times higher than maximum oral dosing. Whether these elevated concentrations translate into durable health benefits for otherwise healthy individuals remains a subject of active investigation, but the pharmacokinetic advantage is well documented. For people with malabsorption, chronic illness, or acute depletion, the clinical rationale is more straightforward.

The core mechanism is simple: a sterile solution containing dissolved nutrients flows through tubing into a peripheral vein, typically in the arm. Because the solution enters the circulatory system directly, it bypasses the entire sequence of oral digestion, including stomach acid, enzymatic breakdown, intestinal absorption, and first-pass metabolism in the liver. This means that virtually 100% of the infused dose becomes immediately available in the bloodstream.

Once circulating, nutrients distribute to tissues according to their individual pharmacokinetics. Water-soluble vitamins like C and the B complex move freely in plasma and are taken up by cells through specific transporters. Minerals such as magnesium and zinc bind to carrier proteins and enter intracellular compartments where they serve as enzyme cofactors. The kidneys filter excess water-soluble nutrients relatively quickly, which is why plasma concentrations spike during infusion and then decline over hours. This transient spike is part of the rationale: some proposed effects, like the pro-oxidant anti-cancer activity of high-dose vitamin C, depend on reaching concentrations that are impossible to sustain orally.

The composition of each IV formulation determines its physiological effects. A basic hydration drip restores fluid volume and electrolyte balance. A Myers' Cocktail combines magnesium, calcium, B1, B2, B3, B5, B6, B12, and vitamin C, targeting energy metabolism and immune support simultaneously. NAD+ infusions deliver a coenzyme central to mitochondrial function and DNA repair. Glutathione infusions supply the body's primary intracellular antioxidant in its reduced, active form. Each formulation operates through distinct biochemical pathways, so "IV therapy" is better understood as a delivery method than a single intervention.

A typical IV therapy session begins with an intake process. At reputable clinics, this includes a review of your medical history, current medications, and, ideally, recent laboratory work. Some providers draw blood on-site before your first infusion to establish baseline nutrient levels and kidney function. Once cleared, a nurse or clinician places a small catheter in a vein, usually in the forearm or the back of the hand. The insertion feels like a standard blood draw.

The infusion itself runs over 30 to 90 minutes, depending on volume and formulation. You sit in a recliner or comfortable chair while the solution drips from a bag through standard medical tubing. Some formulations, particularly those containing magnesium or NAD+, can produce noticeable sensations during the infusion: warmth, flushing, mild chest tightness, or a metallic taste. These effects are generally transient and can often be managed by slowing the drip rate. After the infusion, the catheter is removed and a bandage applied. Most people return to normal activities immediately. Some report a subjective sense of increased energy or mental clarity within hours, though the contribution of hydration alone versus specific nutrients is difficult to separate without controlled conditions.

Protocols vary based on the clinical goal. For acute repletion of documented deficiencies, an initial series of weekly infusions over four to eight weeks is common, followed by reassessment through repeat lab work. Maintenance protocols for individuals with chronic malabsorption or high nutrient demand may involve infusions every two to four weeks on an ongoing basis. Elective wellness users often receive infusions monthly or as needed, such as before travel, during illness, or after periods of high physical or cognitive demand.

There is no universally agreed-upon dosing schedule for healthy individuals, and the optimal frequency depends on individual metabolism, baseline nutrient stores, and how well oral supplementation covers ongoing needs. More is not inherently better: water-soluble nutrients are cleared by the kidneys within hours to days, so frequent infusions provide repeated transient spikes rather than sustained elevation. Periodic lab monitoring helps determine whether the chosen frequency is producing measurable changes in nutrient status.

IV therapy costs vary widely by formulation, provider, and geographic market. Basic hydration drips typically range from $100 to $200 per session. Standard multi-nutrient infusions such as the Myers' Cocktail generally fall between $150 and $350. Specialized formulations, including high-dose vitamin C, NAD+, or glutathione infusions, can range from $250 to $1,000 or more per session, with NAD+ protocols at the higher end due to the cost of the compound and the longer infusion time required.

Most IV therapy for wellness purposes is not covered by insurance, as it falls outside standard medical indications. Some functional medicine practices include IV therapy as part of broader membership or concierge programs, which may reduce the per-session cost. When evaluating expense, it is worth comparing the cost of repeated infusions against the cost of high-quality oral supplementation combined with lab testing to optimize absorption, particularly if the primary goal is maintaining adequate nutrient levels rather than achieving supraphysiologic concentrations.

The evidence base for IV therapy varies considerably depending on the specific formulation and condition being treated. In clinical medicine, IV nutrient delivery is well established for correcting documented deficiencies, managing dehydration, and supporting patients who cannot absorb nutrients orally. High-dose IV vitamin C has been studied in oncology settings, with some randomized controlled trials showing improvements in quality of life and reductions in chemotherapy side effects, though evidence for direct tumor-killing effects in humans remains inconclusive. IV magnesium has strong support for acute uses such as eclampsia and severe asthma exacerbation.

For elective wellness applications in otherwise healthy adults, the evidence is thinner. The original Myers' Cocktail protocol has been described in case series and a small number of controlled trials (notably for conditions like fibromyalgia and acute asthma), with mixed results. Studies on IV glutathione for general wellness, skin brightening, or detoxification are largely limited to small, uncontrolled investigations. NAD+ infusions have generated interest based on preclinical data showing NAD+ decline with aging, but human trials examining intravenous NAD+ for longevity endpoints are still in early stages. A common critique is that many wellness IV clinics extrapolate from the pharmacokinetic advantage (higher blood levels) to clinical benefit (better outcomes) without trials demonstrating the latter in healthy populations. The gap between mechanism and outcome remains significant for most elective formulations.

IV therapy carries procedural risks including vein irritation (phlebitis), bruising, hematoma, and, if sterile technique is not maintained, infection at the insertion site or, rarely, systemic bloodstream infection. Rapid infusion of certain nutrients can cause nausea, flushing, hypotension, or cardiac arrhythmia, particularly with magnesium or potassium. Individuals with impaired kidney function are at elevated risk for electrolyte disturbances because they cannot efficiently clear excess minerals. Pre-existing heart failure increases the risk of fluid overload. Some formulations contain preservatives or additives that can cause allergic reactions. Quality control varies across providers, and compounded IV solutions are not subject to the same regulatory oversight as pharmaceutical products, so sourcing and preparation practices matter. Pre-treatment lab work and a clinical intake that screens for kidney disease, heart conditions, and medication interactions reduce the likelihood of adverse events.